| Exosomes as drug carriers for cancer therapy JE Pullan, MI Confeld, JK Osborn, J Kim, K Sarkar, S Mallik Molecular pharmaceutics 16 (5), 1789-1798, 2019 | 170 | 2019 |
| Overcoming hurdles in nanoparticle clinical translation: The influence of experimental design and surface modification JW Shreffler, JE Pullan, KM Dailey, S Mallik, AE Brooks International journal of molecular sciences 20 (23), 6056, 2019 | 109 | 2019 |
| Strategies to improve the hemocompatibility of biodegradable biomaterials P Mulinti, JE Brooks, B Lervick, JE Pullan, AE Brooks Hemocompatibility of biomaterials for clinical applications, 253-278, 2018 | 38 | 2018 |
| Modified bovine milk exosomes for doxorubicin delivery to triple-negative breast cancer cells J Pullan, K Dailey, S Bhallamudi, L Feng, L Alhalhooly, J Froberg, ... ACS applied bio materials 5 (5), 2163-2175, 2022 | 37 | 2022 |
| Echogenic exosomes as ultrasound contrast agents J Osborn, JE Pullan, J Froberg, J Shreffler, KN Gange, T Molden, Y Choi, ... Nanoscale advances 2 (8), 3411-3422, 2020 | 15 | 2020 |
| Hemocompatibility of Biomaterials for clinical applications P Mulinti, JE Brooks, B Lervick, JE Pullan, AE Brooks Woodhead Publishing, 2018 | 15 | 2018 |
| The evolution and future of targeted cancer therapy: from nanoparticles, oncolytic viruses, and oncolytic bacteria to the treatment of solid tumors KM Pierce, WR Miklavcic, KP Cook, MS Hennen, KW Bayles, ... Nanomaterials 11 (11), 3018, 2021 | 13 | 2021 |
| Energy-triggered drug release from polymer nanoparticles for orthopedic applications JE Pullan, AT Pullan, VB Taylor, BD Brooks, D Ewert, AE Brooks Therapeutic Delivery 8 (1), 5-14, 2017 | 6 | 2017 |
| Nanoparticles for Delivering Natural Product Chemotherapeutics to Breast Cancer Cells JE Pullan, B Mamnoon, N Kale, S Mallik Discovery and Development of Anti-Breast Cancer Agents from Natural Products …, 2021 | 1 | 2021 |
| Natural polymer hydrogel based 3D printed bioreactor testing platform for cancer cell culture C Rehovsky, DS Bajwa, S Mallik, JE Pullan, I Ara Materials Today Communications 39, 108925, 2024 | | 2024 |
| An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic KM Dailey, JM Small, JE Pullan, S Winfree, KE Vance, M Orr, S Mallik, ... Plos one 18 (11), e0289183, 2023 | | 2023 |
| Chemical Modification of Bovine Milk Exosomes, the Biological Nanoparticles of the Future, as a Contrast Agent and Drug Delivery Vehicle JE Pullan North Dakota State University, 2021 | | 2021 |
| Development and characterization of acoustically responsive exosomes for simultaneous imaging and drug delivery applications J Osborn, J Pullan, J Froberg, Y Choi, S Mallik, K Sarkar The Journal of the Acoustical Society of America 145 (3_Supplement), 1894-1894, 2019 | | 2019 |
| Nanoscale Advances d0na00339e J Osborn, JE Pullan, J Froberg, J Shreffler, KN Gange, T Molden, Y Choi, ... | | |
Sanku MallikProfessor, North Dakota State University在 ndsu.edu 的电子邮件经过验证
